Latest Biodel Inc (BIOD) Headlines Biodel enters into

New Post Public Reply Private Reply Replies (0) Message Board

Mar 13, 2014 at 5:56 AM

Latest Biodel Inc (BIOD) Headlines

Biodel enters into commercial manufacturing agreement for Glucagon Rescue Product with Emergent BioSolutions
M2 - Thu Mar 06, 5:05AM CST
Biopharmaceutical company Biodel (NasdaqCM:BIOD) revealed on Wednesday the launch of another agreement for its Glucagon Emergency Management (GEM) development and manufacturing programme with Cangene bioPharma (Emergent BioSolutions).

Biodel Announces Commercial Manufacturing Agreement With Emergent BioSolutions for Glucagon Rescue Product
GlobeNewswire - Wed Mar 05, 3:00PM CST
Biodel Inc. (Nasdaq:BIOD) today announced another development in its Glucagon Emergency Management (GEM) development program with the signing of a long-term manufacturing agreement with Cangene bioPharma Inc. doing business as Emergent BioSolutions ("Emergent"). Under the agreement, Emergent will fill and finish commercial quantities of the GEM device. Financial terms of the agreement have not been disclosed.

Traders Get Bullish on Shares of Biodel, Shares Up 7.8% (BIOD)
Comtex SmarTrend(R) - Tue Mar 04, 10:11AM CST
Biodel (NASDAQ:BIOD) is one of today's best performing low-priced stocks, up 7.8% to $3.47 on 2.7x average daily volume. Biodel has traded 1.3 million shares thus far today, vs. average volume of 472,000 shares per day. The stock has outperformed the Dow (7.8% to the Dow's 1.2%) and outperformed the S&P 500 (7.8% to the S&P's 1.3%) during today's trading.

Biodel to Present at the 26th Annual ROTH Conference
GlobeNewswire - Tue Mar 04, 6:11AM CST
Biodel Inc. (Nasdaq:BIOD) management will be presenting an overview of the Company's technologies, development programs, and outlook at the 26th Annual ROTH Conference being held at the Ritz-Carlton Laguna Niguel, CA from March 9-12, 2014. Interested parties can access a link to a live webcast of the presentation from the News & Events section of the Biodel website, www.biodel.com. The corporate presentation of the Company will take place on Monday, March 10, 2014 at 4:00 p.m. PT.

5 Biotech Stocks to Trade for Breakouts
at The Street - Mon Feb 24, 1:08PM CST
Here's a technical look at five potentially explosive biotech stock plays.

Stock to Watch: Biodel Up 5.9% (BIOD)
Comtex SmarTrend(R) - Mon Feb 24, 11:42AM CST
Biodel (NASDAQ:BIOD) is one of today's best performing low-priced stocks, up 5.9% to $3.22 on 1.1x average daily volume. Biodel has traded 499,000 shares thus far today, vs. average volume of 447,000 shares per day. The stock has outperformed the Dow (5.9% to the Dow's 1.2%) and outperformed the S&P 500 (5.9% to the S&P's 1.2%) during today's trading.

Positive Phase I Data from Biodel - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 4:40PM CST
Biodel's BIOD-531 shows positive phase I study results

Hot Stock: Biodel, Shares Gain 6.9% (BIOD)
Comtex SmarTrend(R) - Thu Feb 13, 10:11AM CST
Biodel (NASDAQ:BIOD) is one of today's best performing low-priced stocks, up 6.9% to $3.24 on 1.6x average daily volume. Biodel has traded 942,000 shares thus far today, vs. average volume of 603,000 shares per day. The stock has outperformed the Dow (6.9% to the Dow's 0.0%) and outperformed the S&P 500 (6.9% to the S&P's 0.1%) during today's trading.

CT Lien Solutions Introduces Electronic Signing and Recording Capabilities for Mortgage Documents at MBA National Mortgage Servicing Conference & Expo
Marketwire - Thu Feb 13, 7:30AM CST
WHAT: CT Lien Solutions, a comprehensive provider of lien and document management solutions to mortgage servicers, financial institutions and law firms nationwide, will showcase its expertise in innovative mortgage solutions for mortgage servicers, featuring iLienRED(TM), at the upcoming Mortgage Bankers Association (MBA) National Servicing Conference and Expo February 18-21, 2014 in Orlando, Florida.

Biodel Q1 Loss Narrows - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 1:49PM CST
Biodel reports a narrower loss in 1Q14.

Biodel Inc announces lower net loss of USD2.4m for Q1 2013
M2 - Fri Feb 07, 7:09AM CST
Biopharmaceutical company Biodel Inc (NasdaqCM:BIOD) on Thursday declared a net loss of USD2.4m, or USD0.12 per share of common stock, for the first fiscal quarter ended 31 December 2013.

Biodel Reports First Quarter Fiscal Year 2014 Financial Results
GlobeNewswire - Thu Feb 06, 3:03PM CST
Biodel Inc. (Nasdaq:BIOD) today reported financial results for the first fiscal quarter ended December 31, 2013.

Avanir Reports Narrower Loss, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 06, 11:40AM CST
Avanir Pharma reported first quarter fiscal 2014 net loss per share of 7 cents, narrower than the Zacks Consensus Estimate of a loss of 8 cents

Biodel to Report First Quarter Fiscal Year 2014 Financial Results on February 6, 2014
GlobeNewswire - Wed Feb 05, 3:00PM CST
Biodel Inc. (Nasdaq:BIOD) will issue its first quarter fiscal year 2014 financial results on February 6, 2014. Following the release of the company's financial results, Biodel's senior management will host a conference call to discuss the results and provide an update on the company's progress.

Biodel to Present at Upcoming Conferences
GlobeNewswire - Tue Feb 04, 9:49PM CST
Biodel Inc. (Nasdaq:BIOD) announced today that it will present at the following upcoming conferences:

Why Actavis (ACT) Has A Bright Short-Term Future? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 22, 7:42AM CST
Actavis has seen its Zacks Rank move up from Neutral to Strong Buy over the past four weeks

ARIAD's Iclusig Returns to U.S. - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 5:10PM CST
ARIAD is set to resume marketing of Iclusig in the U.S.

Biodel Up 7.6%, Shares Break Through Resistance (BIOD)
Comtex SmarTrend(R) - Wed Jan 15, 11:42AM CST
Biodel (NASDAQ:BIOD) is one of today's best performing low-priced stocks, up 7.6% to $3.24 on 1.1x average daily volume. Biodel has traded 868,000 shares thus far today, vs. average volume of 781,000 shares per day. The stock has outperformed the Dow (7.6% to the Dow's 0.8%) and outperformed the S&P 500 (7.6% to the S&P's 0.6%) during today's trading.

Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc
ACCESSWIRE - Fri Jan 03, 9:01AM CST
New York, January 03, 2014 / Accesswire / - Market Buzz Report, which provides live alerts on penny stocks, issues critical stocks analysis for Plug Power Inc (NASDAQ

LUG), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Biodel Inc (NASDAQ:BIOD), Apple Inc.(NASDAQ:AAPL).

5 Stocks Under $10 Set to Soar
at The Street - Thu Jan 02, 12:11PM CST
These under-$10 stocks look ready to trade higher from current levels.

Biodel Inc. (BIOD) Stock Research Links

BIOD Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LV Petroleum Expands Footprint with Key Acquisitions

LV Petroleum's Bold Moves in July Ever seen a company expand across four states in a blink? LV Petroleum's been hustling like a player with a fresh hand of aces. They shut July down with restaurant openings and a fancy new travel center under their belt in states as spread out as Arizona, Texas, Nevada, and Ohio. Now that's a wide net they're casting, all in the name of...

Decoding Historic Home Buys: Tips for New Owners

Realities Behind the Rustic Facade Picture this: you’re standing in front of a crumbling beauty with crown molding and character oozing from its very walls. Now what? It's easy to get swept away by the allure of a historic home, but there's gritty work to be done under those charming facades. Enter Debi Beiland of Limestone Properties over in Maysville, KY. She’s got...

Project 777 Bolsters Leadership with AI and Space Experts

Fortifying Project 777 with Tech Titans You'd think bolstering a team THIS stacked would feel daunting to others in the AI race, but A2035 Ventures is just getting started. Their latest move? Bringing in Sean Perry from Meta's Agentic AI and Preston Dunlap, ex-CTO of the U.S. Space Force. These aren't your garden-variety hires; they signify a deliberate step into the next...

Hydrogen Mobility Gains Steam: Industry & Policy Unite

The winds are changing, and this time, it's hydrogen that's blowing into town. Europe may just be on the brink of a major trucking overhaul, driven by a concoction of industry giants and supportive policies. The stage is set for hydrogen trucks to roll out by 2030, aiming to gut traditional fuel options and stack the odds in favor of zero-emission transport. Can you smell...

Globant Unleashes MuleSoft AI Pod for Faster Integration

Unlocking the AI Puzzle: Webinar Speed Dials You ever swim through a mash-up of tech lingo that makes you feel like you're trudging through waist-high molasses? Well, Saddle up because that's exactly where Globant's new MuleSoft AI Pod is heading. Through Glob.AI, they're going all in on turning what used to take months into mere weeks—finally, right? In the business of...

Travel Smart: Support Wildlife, Avoid Exploitation

Rethink Wildlife Tourism for Ethical Travel You ever stopped to think about what those so-called wildlife attractions are really selling? It’s a feel-good illusion wrapped up in exploitation. Travelers often see animals as part of the backdrop of their holiday stories, but the reality is far from picturesque. Behind the photo ops, there's typically a grim story of...

Regeneron: Investors Face Class Action Over Study Flaws

Regeneron Investors Grit Teeth Amid Lawsuit Drama The gloves are off in the pharmaceutical battleground, folks. Investors who thought they were riding the big wave with Regeneron Pharmaceuticals (NASDAQ: REGN) are now staring down the barrel of a class action lawsuit. It seems the company’s been caught in a storm of legal action following allegations of misleading...

Potassium Fluoride Market Growth Sparks Interest

Here's a story you might not have expected—potassium fluoride is finding its spotlight! With the market projected to tick upwards from USD 0.43 billion in 2026 to USD 0.51 billion by 2032, there's more here than meets the eye. A steady CAGR of 2.9% might not scream excitement, but steady growth often does the trick in chemicals. Why the Buzz Around Potassium Fluoride?...

Gan & Lee's Global Gamble: Europe Beckons with Menarini

Shifting Gears: Gan & Lee's Major European Play Picture it—Asian biopharma juggernaut Gan & Lee Pharmaceuticals is hitching a ride with Europe's Menarini Group to take its flagship, bofanglutide, across the vast European market. It's a move that's got shades of grand ambition, colorful strategy, and not a small sum riding on its success. Cracking the Metabolic Code The...

University of Phoenix Boosts Networking Strategies

Building Networks: A Key to Professional Growth Listen up, because everyone and their dog is gabbing about mentorship and networking these days—and for good reason. The University of Phoenix is cracking this nut open with their latest webinar, "Build the Network That Advances Your Career: Mentors, Peers & Community," happening on September 17th. They're not just...